Is CX a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Cemex (CX) rests on US aggregates and infrastructure tilt: Cemex has been redeploying proceeds from smaller-market exits into US aggregates (for example the Couch Aggregates acquisition), shifting the mix toward higher-margin, longer-life materials. Revenue (2025 FY) is ~$16.1B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Cemex is a deeply cyclical business whose demand swings with construction and infrastructure spending, so a downturn or higher-for-longer interest rates could pressure volumes and pricing. Whether CX is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Cemex (NYSE: CX) is a global building-materials company that makes and sells cement, ready-mix concrete, and aggregates (crushed stone, sand, and gravel), along with related urbanization and infrastructure products. It operates across five reportable segments (Mexico, the United States, Europe, the Middle East and Africa, and South, Central America and the Caribbean), with the US and Mexico together accounting for roughly 60% of 2025 revenue. The US-listed security is an ADR representing the underlying Mexican shares; the company is one of the largest cement producers in the world alongside Holcim, Heidelberg Materials, and CRH. The investment picture centers on a cyclical, capital-intensive business tied to construction and infrastructure spending, layered with company-specific self-help. Over 2024 and 2025 Cemex pushed pricing discipline and its efficiency programs (branded Project Cutting Edge), cut net debt toward roughly $5.0 billion, and reshaped its portfolio by exiting smaller markets (Guatemala, the Philippines, the Dominican Republic, most of Panama) while redeploying capital into US aggregates through acquisitions such as Couch Aggregates. Results into 2026 showed record quarterly EBITDA and expanding margins, but the stock remains sensitive to interest rates, US and Mexican construction activity, foreign-exchange swings, and energy input costs.
What's the case for buying CX?
1. US aggregates and infrastructure tilt
Cemex has been redeploying proceeds from smaller-market exits into US aggregates (for example the Couch Aggregates acquisition), shifting the mix toward higher-margin, longer-life materials. US infrastructure spending and reshoring-driven nonresidential construction are the key demand drivers for this pivot.
2. Margin self-help and efficiency programs
The Project Cutting Edge efficiency program and pricing discipline drove record EBITDA and meaningful margin expansion, with Q1 2026 EBITDA up about 34% year over year and margin near 19.8%. Management has hit recurring cost-savings targets, which supports profitability even when volumes are soft.
3. Deleveraging and capital returns
Net debt fell roughly 15% to about $5.0 billion in 2025, lowering leverage toward 1.63x, and the company raised its dividend and added buybacks. A cleaner balance sheet reduces refinancing risk and frees cash flow for shareholder returns and reinvestment.
4. Mexico and emerging-market demand
Mexico remains one of Cemex's most profitable segments, with EBITDA margins in the mid-30s, and it benefits from nearshoring-driven industrial and infrastructure construction. Emerging-market exposure adds growth potential but also currency and macro volatility.
What are the risks to CX?
Cemex is a deeply cyclical business whose demand swings with construction and infrastructure spending, so a downturn or higher-for-longer interest rates could pressure volumes and pricing. As a Mexico-based operator with an ADR listing, it carries meaningful emerging-market and foreign-exchange risk, with most debt in dollars but large revenue in pesos and other currencies. Energy and fuel costs are a major input and can compress margins, and the company recorded goodwill impairments and asset write-downs (about $538 million in 2025). Regulatory, carbon-emission, and geopolitical exposure across its Middle East, Africa, and Latin American footprint add further uncertainty, and the elevated trailing valuation leaves little room for execution missteps.
How is CX valued? (as of July 2026)
Snapshot for CX as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (2025 FY): ~$16.1B
- Revenue (Q1 2026, YoY): ~$4.0B (+11%)
- EBITDA (Q1 2026): ~$794M (+34%)
- Adjusted net income (2025): ~$1.5B
- Net debt / leverage: ~$5.0B (~1.6x)
- Market cap: ~$18B
Cemex trades around $12 per ADR with a trailing P/E in the high 30s but a forward P/E near 18, reflecting expectations of rising earnings as efficiency programs and US aggregates flow through. Full-year 2025 revenue was roughly flat versus 2024, but adjusted profitability improved sharply on cost savings and pricing. Figures are approximate and based on 2025 filings and Q1 2026 results.
How do you decide if CX is a buy?
Rather than asking whether CX is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold CX indirectly through an index or sector ETF before adding more.
For the full picture, see the CX stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CX against your real portfolio and see your actual exposure before deciding.
The bottom line on CX
The bottom line: Cemex's story right now is US aggregates and infrastructure tilt, with revenue (2025 fy) at ~$16.1B. If you believe that narrative continues, the call is about sizing CX sensibly and checking overlap with what you own; if you doubt it (the risk: cemex is a deeply cyclical business whose demand swings with construction and infrastructure spending, so a downturn or higher-for-longer interest rates could pressure volumes and pricing.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around CX with Walnut
Use Cemex as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is CX a good stock to buy right now?
+
The case for Cemex right now is US aggregates and infrastructure tilt, with revenue (2025 fy) at ~$16.1B. If you believe that thesis holds, CX is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is cemex is a deeply cyclical business whose demand swings with construction and infrastructure spending, so a downturn or higher-for-longer interest rates could pressure volumes and pricing. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Cemex do?
+
Cemex (NYSE: CX) is a global building-materials company that makes and sells cement, ready-mix concrete, and aggregates (crushed stone, sand, and gravel), along with related urbani
What are the main risks of CX?
+
Cemex is a deeply cyclical business whose demand swings with construction and infrastructure spending, so a downturn or higher-for-longer interest rates could pressure volumes and pricing. As a Mexico-based operator with an ADR listing, it carries meaningful emerging-market and foreign-exchange risk, with most debt in dollars but large revenue in pesos and other currencies. Energy and fuel costs are a major input and can compress margins, and the company recorded goodwill impairments and asset write-downs (about $538 million in 2025). Regulatory, carbon-emission, and geopolitical exposure across its Middle East, Africa, and Latin American footprint add further uncertainty, and the elevated trailing valuation leaves little room for execution missteps.
What does Cemex (CX) do?
+
Cemex produces and sells cement, ready-mix concrete, and aggregates such as crushed stone, sand, and gravel, plus related urbanization products. It is one of the largest building-materials companies in the world, serving construction and infrastructure customers across the Americas, Europe, the Middle East, and Africa.
Is CX a stock or an ADR?
+
CX is an American Depositary Receipt (ADR) listed on the NYSE that represents the underlying shares of Cemex, S.A.B. de C.V., a company headquartered in Monterrey, Mexico. The ordinary shares also trade on the Mexican stock exchange.
How does Cemex make money?
+
Cemex earns revenue by selling cement, ready-mix concrete, and aggregates to construction and infrastructure customers. Its largest markets are the United States and Mexico, which together made up roughly 60% of 2025 revenue, with the rest spread across Europe, the Middle East and Africa, and Latin America and the Caribbean.
What were Cemex's recent results?
+
Full-year 2025 revenue was about $16.1 billion, roughly flat versus 2024, while adjusted net income rose to about $1.5 billion on cost savings. In Q1 2026 sales grew about 11% to roughly $4.0 billion and EBITDA reached a record near $794 million, up about 34% year over year.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell CX; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.